Cited 0 times in
Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An expanded dataset
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.